Table 3.
Glycemic control, long-term diabetes complications, and treatment modalities of diabetic patients with and without bursitis/tendonitis (N=100)
| Feature (%) | Bursitis/ tendinitis (n=59) |
No bursitis/ tendinitis (n=41) |
p value |
|---|---|---|---|
| DM duration, mean (SD) years | 11.6 (10.0) | 10.2 (11.1) | 0.510 |
| Fasting blood sugar, mean (SD) mg/dl | 143.5 (71.7) | 171.0 (103.0) | 0.357 |
| Glycosylated Hg, mean (SD) % | 8.3 (2.0) | 8.5 (2.6) | 0.959 |
| Neurologic involvement, % | 54.2 | 46.3 | 0.437 |
| Peripheral neuropathy | 47.5 | 39.0 | 0.403 |
| Gastroparesis | 3.4 | 0.0 | 0.511 |
| Neurogenic bladder | 10.2 | 4.9 | 0.466 |
| Cerebrovascular accident | 6.8 | 7.3 | 0.999 |
| Renal involvement, % | 42.4 | 34.2 | 0.407 |
| Microalbuminuria | 20.3 | 17.1 | 0.682 |
| End-stage renal disease | 3.4 | 2.4 | 0.999 |
| Retinopathy, % | 27.1 | 17.1 | 0.240 |
| Non-proliferative | 11.9 | 9.8 | 0.999 |
| Proliferative | 16.9 | 7.3 | 0.229 |
| Cataracts, % | 27.1 | 4.9 | 0.007 |
| Cardiovascular complications, % | 37.3 | 26.8 | 0.274 |
| Peripheral vascular disease | 27.1 | 4.9 | 0.004 |
| Myocardial infarction | 11.9 | 9.8 | 0.999 |
| Angina | 16.9 | 19.5 | 0.743 |
| PTCA | 3.4 | 0.0 | 0.511 |
| CABG | 5.1 | 0.0 | 0.267 |
| Congestive heart failure | 1.7 | 2.4 | 0.999 |
| DM treatments, % | |||
| Insulin alone | 23.7 | 26.8 | 0.725 |
| Oral medications alone | 33.9 | 24.4 | 0.308 |
| Oral medications + insulin | 40.7 | 48.8 | 0.422 |
DM diabetes mellitus, SD standard deviation, Hg hemoglobin, PTCA percutaneous coronary angioplasty, CABG coronary arteries bypass graft